Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
QuintilesIMS
Teva
Chinese Patent Office
AstraZeneca
UBS
Julphar
McKinsey

Generated: August 17, 2018

DrugPatentWatch Database Preview

Barr Labs Inc Company Profile

« Back to Dashboard

What is the competitive landscape for BARR LABS INC, and what generic and branded alternatives to BARR LABS INC drugs are available?

BARR LABS INC has seventeen approved drugs.

There are three tentative approvals on BARR LABS INC drugs.

Summary for Barr Labs Inc
US Patents:0
Tradenames:16
Ingredients:15
NDAs:17

Drugs and US Patents for Barr Labs Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr Labs Inc METHYLPHENIDATE HYDROCHLORIDE methylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 079031-002 Jul 13, 2012 AB1 RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Barr Labs Inc MINOCYCLINE HYDROCHLORIDE minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 065485-007 Apr 26, 2017 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Barr Labs Inc DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 076536-006 Feb 12, 2013 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Barr Labs Inc MINOCYCLINE HYDROCHLORIDE minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 065485-005 May 18, 2012 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Barr Labs Inc OLANZAPINE olanzapine TABLET, ORALLY DISINTEGRATING;ORAL 077243-003 Jan 30, 2012 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Barr Labs Inc MINOCYCLINE HYDROCHLORIDE minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 065485-002 Mar 17, 2009 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Barr Labs Inc DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 076536-001 Feb 12, 2013 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
QuintilesIMS
Johnson and Johnson
Covington
Citi
McKinsey
Federal Trade Commission
US Army
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.